Obermatt
See Similar Stocks →

Fresenius Medical Care

GER:FME · DE0005785802
Health Care Providers & ServicesX-Large

360

31
EV / EBIT77
Price / Owner Earnings44
Owner Earnings Yield64
Dividend Yield85
Price/Sales65
EV / Gross Profit69
Price/Book76
Return on Capital52
Cash Return on Capital47
Return on Equity59
EBIT Margin69
Gross Profitability17
Cash Conversion64
Accruals55
Owner Earnings Margin53
Sales growth8
Profit Growth84
Long-Term EPS Growth29
Owner Earnings Growth49
Reinvestment27
Price momentum23
Debt load49
Refinancing74
Debt Payback19
Liquidity57
Analyst ratings12
Opinion Changes55
Price Target Upside34
Market mood53
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Fresenius Medical Care clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryGermany
IndustryHealth Care Providers & Services
SizeX-Large
TypePublic Company
ExchangeXTRA
Founded1996
Employees16,504
Websitefreseniusmedicalcare.com
ISINDE0005785802
Last UpdateApr 2, 2026
Indices
CDAX (Germany)DAX 40 (Germany)
Themes
Health DiagnosticsCardiovascularBiomedical EngineeringHematologyNephrologyChronic DiseasesSurgeryBiotechnologyHealth CareMedical Device

Description

Fresenius Medical Care AG (Fresenius Medical Care) provides products and services for individuals with kidney diseases. As a vertically integrated medical technology (MedTech) and healthcare service company, Fresenius Medical Care combines medical d…

Analysis

Bargain bin

Fresenius Medical Care AG is priced cheaply, and that invites the natural question of why, since the underlying business scores below average.

On valuation, the picture is attractive. The owner-earnings multiple stands at 14.4×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 2% a year, against analyst forecasts of 7%. The price, in other words, assumes less than the experts do.

Growth is tepid; the safety picture is adequate. The company scores 10/20 on our value-creation score: creating some value. Analyst sentiment is cautious.

Flags to be aware of: A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
37
2023202420252026

All-time high

82

Feb 2026

All-time low

31

Jan 2023

Average rank

64

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
65
69
72
75
Price/Earnings
19
77
77
89
Price/Book
76
82
84
84
Dividend Yield
85
92
79
76
Value (overall)
61
94
82
85

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Fresenius Medical Care with its peers
Fresenius
GER:FRE
49
CountryGermany
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
SHL Telemedicine
SWX:SHLTN
24
CountryIsrael
IndustryHealth Care Providers & Services
SizeX-Small
Full Stock Analysis →
Getinge
STO:GETI B
63
CountrySweden
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Prosegur
MCE:PSG
61
CountrySpain
IndustryCommercial Services & Supplies
SizeLarge
Full Stock Analysis →
Spire
LSE:SPI
38
CountryUK
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Uniphar
ISE:UPR
59
CountryIreland
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →